Head-to-Head

Abbott Laboratories vs. Theravance Biopharma, Inc.

ABT

Abbott Laboratories

$111.59 -2.20%

VS TBPH

Theravance Biopharma, Inc.

$17.04 +0.06%

Abbott Laboratories (ABT) comes out ahead, leading on 5 of 9 compared factors.

Size & Scale

ABTTBPH
Market Cap $197.44 billion $884.18 million
Revenue (TTM) $46.59 billion $104.31 million
Net Income (TTM) $5.42 billion $53.81 million

ABT leads on 3 of 3 size & scale factors.

Valuation

ABTTBPH
P/E Ratio 36.11 16.87
Price / Book 3.81 3.05
Price / Sales 4.24 8.48

TBPH leads on 2 of 3 valuation factors.

Profitability

ABTTBPH
Net Margin 11.65% 51.58%
Return on Equity 10.48% 18.57%

TBPH leads on 2 of 2 profitability factors.

Dividend

ABTTBPH
Dividend Yield 2.26% —
Payout Ratio 81.55 —

ABT and TBPH split the dividend factors evenly.

Risk & Sentiment

ABTTBPH
Short Interest 0.57% 11.71%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, TBPH overview, TBPH financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.